[Journal logo]

Volume 66 
Part 2 
Pages o457-o458  
February 2010  

Received 21 January 2010
Accepted 22 January 2010
Online 27 January 2010

Key indicators
Single-crystal X-ray study
T = 120 K
Mean [sigma](C-C) = 0.003 Å
R = 0.046
wR = 0.133
Data-to-parameter ratio = 15.6
Details
Open access

(E)-1-(3-Nitrophenyl)-2-({5-[(1E)-2-(3-nitrophenyl)hydrazin-1-ylidenemethyl]-2-thienyl}methylidene)hydrazine

aDepartamento de Quimica, ICEx, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, Brazil,bDepartment of Chemistry, University of Aberdeen, Meston Walk, Old Aberdeen AB24 3UE, Scotland,cDepartment of Chemistry, University of Malaya, 50603 Kuala Lumpur, Malaysia,dCentro de Desenvolvimento Tecnológico em Saúde (CDTS), Fundação Oswaldo Cruz (FIOCRUZ), Casa Amarela, Campus de Manguinhos, Av. Brasil 4365, 21040-900 Rio de Janeiro, RJ, Brazil, and eCHEMSOL, 1 Harcourt Road, Aberdeen AB15 5NY, Scotland
Correspondence e-mail: edward.tiekink@gmail.com

The title molecule, C18H14N6O4S, adopts a U-shape with the aromatic groups lying syn and oriented in the same direction as the thiophene S atom. Twists away from planarity are evident with the maximum deviation being found for a terminal nitro group: C/C/N/O = 19.0 (3)°. The conformation about each of the C=N bonds is E. In the crystal, centrosymmetrically related molecules are connected via N-H...Onitro hydrogen bonds, forming 14-membered {...HNC3NO}2 synthons. These are linked into layers via C-H...Onitro interactions with the primary interactions between layers being of the type C-H...[pi], where the [pi]-system is the thiophene ring.

Related literature

For the preparation of hydrazones of thiophenecarbaldehydes, see: Kwon et al. (2009[Kwon, O.-P., Jazbinsek, M., Seo, J.-I., Kim, P.-J., Yun, H., Lee, Y. S. & Gunter, P. (2009). J. Phys. Chem. C, 113, 15405-15411.]); Wardell et al. (2007[Wardell, J. L., Low, J. N. & Glidewell, C. (2007). Acta Cryst. E63, o1848-o1850.]); Vaysse & Pastour (1964[Vaysse, M. & Pastour, P. (1964). Compt. Rend. 259, 2657-2659.]). For general uses of 2-substituted-thiophenes, see: Campaigne (1984[Campaigne, E. (1984). Comprehensive Heterocyclic Chemistry, Vol. 4, edited by A. R. Katritzky & C. W. Rees, pp. 863-934. Oxford: Pergamon.]). For their specific uses as materials, see: Michaleviciute et al. (2007[Michaleviciute, A., Buika, G., Grazulevicius, J. V., Tran-Van, F., Chevrot, C. & Jankauskas, V. (2007). Mol. Cryst. Liq. Cryst. 468, 459-470.], 2009[Michaleviciute, A., Lygaitis, R., Grazulevicius, J. V., Buika, G., Jankauskas, V., Undzenas, A. & Fataraite, E. (2009). Synth. Met. 159, 223-227.]); Kwon et al. (2009[Kwon, O.-P., Jazbinsek, M., Seo, J.-I., Kim, P.-J., Yun, H., Lee, Y. S. & Gunter, P. (2009). J. Phys. Chem. C, 113, 15405-15411.]). For their specific uses as pharmacological agents, see: Kleemann et al. (2006[Kleemann, A., Engel, J. B., Kutscher, B. & Reichert, D. (2006). In Pharmaceutical Substances. New York, Stuttgart: Georg Thieme Verlag.]); Sonar & Crooks (2009[Sonar, V. N. & Crooks, P. A. (2009). J. Enz. Inhib. Med. Chem. 24, 117-124]); Mellado et al. (2009[Mellado, O. G. & Cortes, E. C. (2009). Mex. Pat. Appl. CODEN: MXXXA3 MX 2007012608 A 20090413.]); Satyanarayana et al. (2008[Satyanarayana, V. S. V., Sreevani, P., Sivakumar, A. & Vijayakumar, V. (2008). ARKIVOC, pp. 221-233.]); Lourenço et al. (2007[Lourenço, M. C. S., Vicente, F. R., Henriques, M., das, G. M. de O., Candéa, A. L. P., Gonçalves, R. S. B., Nogueira, T. C. M., Ferreira, M. de L. & de Souza, M. V. N. (2007). Bioorg. Med. Chem. Lett. 17, 6895-6898.]). For related structures, see: Wardell et al. (2007[Wardell, J. L., Low, J. N. & Glidewell, C. (2007). Acta Cryst. E63, o1848-o1850.], 2010[Wardell, S. M. S. V., de Lima, G. M., Tiekink, E. R. T. & Wardell, J. L. (2010). Acta Cryst. E66, o271-o272.]); Ferreira et al. (2009[Ferreira de Lima, M., de Souza, M. V. N., Tiekink, E. R. T., Wardell, J. L. & Wardell, S. M. S. V. (2009). Acta Cryst. E65, o3203.]); Nogueira et al. (2010[Nogueira, T. C. M., de Souza, M. V. N., Wardell, J. L., Wardell, S. M. S. V. & Tiekink, E. R. T. (2010). Acta Cryst. E66, o177.]).

[Scheme 1]

Experimental

Crystal data
  • C18H14N6O4S

  • Mr = 410.41

  • Monoclinic, P 21 /c

  • a = 11.1790 (5) Å

  • b = 20.6993 (9) Å

  • c = 8.0334 (2) Å

  • [beta] = 100.513 (2)°

  • V = 1827.70 (12) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 0.22 mm-1

  • T = 120 K

  • 0.62 × 0.10 × 0.06 mm

Data collection
  • Nonius KappaCCD area-detector diffractometer

  • Absorption correction: multi-scan (SADABS; Sheldrick, 2007[Sheldrick, G. M. (2007). SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]) Tmin = 0.668, Tmax = 0.746

  • 21780 measured reflections

  • 4183 independent reflections

  • 3001 reflections with I > 2[sigma](I)

  • Rint = 0.071

Refinement
  • R[F2 > 2[sigma](F2)] = 0.046

  • wR(F2) = 0.133

  • S = 1.08

  • 4183 reflections

  • 268 parameters

  • H atoms treated by a mixture of independent and constrained refinement

  • [Delta][rho]max = 0.27 e Å-3

  • [Delta][rho]min = -0.34 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
N2-H2n...O2i 0.89 (2) 2.27 (2) 3.103 (2) 156 (2)
C2-H2...O3ii 0.95 2.46 3.278 (3) 145
C18-H18...O4iii 0.95 2.48 3.241 (3) 137
C12-H12...Cg1iv 0.95 2.58 3.323 (2) 135
Symmetry codes: (i) -x+1, -y+1, -z+2; (ii) x-1, y, z+1; (iii) x, y, z+1; (iv) [x, -y+{\script{3\over 2}}, z-{\script{1\over 2}}].

Data collection: COLLECT (Hooft, 1998[Hooft, R. W. W. (1998). COLLECT. Nonius BV, Delft, The Netherlands.]); cell refinement: DENZO (Otwinowski & Minor, 1997[Otwinowski, Z. & Minor, W. (1997). Methods in Enzymology, Vol. 276, Macromolecular Crystallography, Part A, edited by C. W. Carter Jr & R. M. Sweet, pp. 307-326. New York: Academic Press.]) and COLLECT; data reduction: DENZO and COLLECT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: ORTEP-3 (Farrugia, 1997[Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.]) and DIAMOND (Brandenburg, 2006[Brandenburg, K. (2006). DIAMOND. Crystal Impact GbR, Bonn, Germany.]); software used to prepare material for publication: publCIF (Westrip, 2010[Westrip, S. P. (2010). publCIF. In preparation.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: HG2635 ).


Acknowledgements

The use of the EPSRC X-ray crystallographic service at the University of Southampton, England, and the valuable assistance of the staff there is gratefully acknowledged. JLW acknowledges support from CAPES (Brazil).

References

Brandenburg, K. (2006). DIAMOND. Crystal Impact GbR, Bonn, Germany.
Campaigne, E. (1984). Comprehensive Heterocyclic Chemistry, Vol. 4, edited by A. R. Katritzky & C. W. Rees, pp. 863-934. Oxford: Pergamon.
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.  [CrossRef] [details]
Ferreira de Lima, M., de Souza, M. V. N., Tiekink, E. R. T., Wardell, J. L. & Wardell, S. M. S. V. (2009). Acta Cryst. E65, o3203.  [CrossRef] [details]
Hooft, R. W. W. (1998). COLLECT. Nonius BV, Delft, The Netherlands.
Kleemann, A., Engel, J. B., Kutscher, B. & Reichert, D. (2006). In Pharmaceutical Substances. New York, Stuttgart: Georg Thieme Verlag.
Kwon, O.-P., Jazbinsek, M., Seo, J.-I., Kim, P.-J., Yun, H., Lee, Y. S. & Gunter, P. (2009). J. Phys. Chem. C, 113, 15405-15411.  [CrossRef] [ChemPort]
Lourenço, M. C. S., Vicente, F. R., Henriques, M., das, G. M. de O., Candéa, A. L. P., Gonçalves, R. S. B., Nogueira, T. C. M., Ferreira, M. de L. & de Souza, M. V. N. (2007). Bioorg. Med. Chem. Lett. 17, 6895-6898.  [PubMed]
Mellado, O. G. & Cortes, E. C. (2009). Mex. Pat. Appl. CODEN: MXXXA3 MX 2007012608 A 20090413.
Michaleviciute, A., Buika, G., Grazulevicius, J. V., Tran-Van, F., Chevrot, C. & Jankauskas, V. (2007). Mol. Cryst. Liq. Cryst. 468, 459-470.  [CrossRef] [ChemPort]
Michaleviciute, A., Lygaitis, R., Grazulevicius, J. V., Buika, G., Jankauskas, V., Undzenas, A. & Fataraite, E. (2009). Synth. Met. 159, 223-227.  [ISI] [CrossRef] [ChemPort]
Nogueira, T. C. M., de Souza, M. V. N., Wardell, J. L., Wardell, S. M. S. V. & Tiekink, E. R. T. (2010). Acta Cryst. E66, o177.  [CSD] [CrossRef] [details]
Otwinowski, Z. & Minor, W. (1997). Methods in Enzymology, Vol. 276, Macromolecular Crystallography, Part A, edited by C. W. Carter Jr & R. M. Sweet, pp. 307-326. New York: Academic Press.
Satyanarayana, V. S. V., Sreevani, P., Sivakumar, A. & Vijayakumar, V. (2008). ARKIVOC, pp. 221-233.
Sheldrick, G. M. (2007). SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Sonar, V. N. & Crooks, P. A. (2009). J. Enz. Inhib. Med. Chem. 24, 117-124  [CrossRef] [ChemPort]
Vaysse, M. & Pastour, P. (1964). Compt. Rend. 259, 2657-2659.  [ChemPort]
Wardell, S. M. S. V., de Lima, G. M., Tiekink, E. R. T. & Wardell, J. L. (2010). Acta Cryst. E66, o271-o272.  [CSD] [CrossRef] [details]
Wardell, J. L., Low, J. N. & Glidewell, C. (2007). Acta Cryst. E63, o1848-o1850.  [CSD] [CrossRef] [details]
Westrip, S. P. (2010). publCIF. In preparation.


Acta Cryst (2010). E66, o457-o458   [ doi:10.1107/S1600536810002771 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.